To assess the risk of disease reactivation during pregnancy after natalizumab suspension in women with multiple sclerosis (MS).
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks / Portaccio, Emilio; Moiola, Lucia; Martinelli, Vittorio; Annovazzi, Pietro; Ghezzi, Angelo; Zaffaroni, Mauro; Lanzillo, Roberta; Brescia Morra, Vincenzo; Rinaldi, Francesca; Gallo, Paolo; Tortorella, Carla; Paolicelli, Damiano; Pozzilli, Carlo; De Giglio, Laura; Cavalla, Paola; Cocco, Eleonora; Marrosu, Maria Giovanna; Solaro, Claudio; Uccelli, Antonio; Laroni, Alice; Pastò, Luisa; Giannini, Marta; Trojano, Maria; Comi, Giancarlo; Amato, Maria Pia. - In: NEUROLOGY. - ISSN 0028-3878. - 90:10(2018), pp. e832-e839-e839. [10.1212/WNL.0000000000005068]
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks
Lanzillo, RobertaMembro del Collaboration Group
;Brescia Morra, VincenzoMembro del Collaboration Group
;
2018
Abstract
To assess the risk of disease reactivation during pregnancy after natalizumab suspension in women with multiple sclerosis (MS).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
